DOA
IMUC

D'Orazio & Associates’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

D'Orazio & Associates’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-75
Closed – – 354
2017
Q2 		$0 Hold
75
– – ﹤0.01% 359
2017
Q1 		$0 Hold
75
– – ﹤0.01% 311
2016
Q4 		$0 Hold
75
– – ﹤0.01% 303
2016
Q3 		$0 Hold
75
– – ﹤0.01% 320
2016
Q2 		$1K Hold
75
– – ﹤0.01% 290
2016
Q1 		$0 Buy
+75
New +$844 ﹤0.01% 333

Other funds holding IMUC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return